Latest News about DVAX
Recent news which mentions DVAX
The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows
August 21, 2018
From Benzinga
The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns
August 17, 2018
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
48 Biggest Movers From Yesterday
May 17, 2018
From Benzinga
32 Stocks Moving In Thursday's Mid-Day Session
May 17, 2018
From Benzinga
55 Biggest Movers From Yesterday
May 10, 2018
From Benzinga
40 Stocks Moving In Thursday's Mid-Day Session
May 10, 2018
From Benzinga
32 Stocks Moving In Thursday's Pre-Market Session
May 10, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway
May 09, 2018
From Benzinga
11 Stocks Moving In Monday's After-Hours Session
April 16, 2018
From Benzinga
Benzinga Pro's 5 Stocks To Watch Today
April 16, 2018
From Benzinga
23 Stocks Moving In Monday's Pre-Market Session
April 16, 2018
From Benzinga
The Week Ahead In Biotech: PDUFA Dates, IPOs And More
April 13, 2018
From Benzinga
These 3 Stocks Shot Up 100% in 2017 -- Are They Still Buys?
March 02, 2018
From Motley Fool
Dynavax Clears Heplisav-B Hurdle With CDC Recommendation
February 21, 2018
From Benzinga
The Week Ahead In Biotech: Earnings, PDUFA Dates And More
February 19, 2018
From Benzinga
Benzinga's Top Upgrades, Downgrades For February 14, 2018
February 14, 2018
From Benzinga
25 Stocks Moving In Wednesday's Pre-Market Session
January 24, 2018
From Benzinga
3 Stocks That Could Put NVIDIA's Returns to Shame
January 21, 2018
From Motley Fool
1 Reason Dynavax Technologies Corporation Stock Soared in 2017
January 08, 2018
From Motley Fool
The 10 Best Stocks of 2017
January 07, 2018
From Motley Fool
The Companies That Led 2017's Biotech Rally
December 22, 2017
From Benzinga
3 Growth Stocks to Own in 2018
December 18, 2017
From Motley Fool
FDA Decisions In November: The Month In Review
December 01, 2017
From Benzinga
From Benzinga
Ultragenyx Seeks An FDA Win For Biologic Therapy Candidate
November 14, 2017
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.